UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 8, 2022
(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (512 ) 716-0808
| Not Applicable | ||||||||
| (Former Name or Former Address, if Changed since Last Report) | ||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition.
The information in this Current Report, including the accompanying exhibit, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
On November 8, 2022 , Iteris, Inc. issued a press release announcing its financial results for its fiscal second quarter for the year ended March 31, 2023. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits. The following exhibits are being furnished herewith:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 8, 2022 | ||||||||
| ITERIS, INC., | ||||||||
| a Delaware corporation | ||||||||
| By: | /s/ DOUGLAS L. GROVES | |||||||
| Douglas L. Groves | ||||||||
| Senior Vice President and Chief Financial Officer | ||||||||
Exhibit 99.1
Iteris Reports Record Fiscal 2023 Second Quarter Total Revenue of $39.3 Million and Record Total Ending Backlog of $111.8 Million
Raises the low-end of fiscal 2023 revenue guidance to a range of $150 million to $155 million, representing 14% year over year growth at the mid-point of the guidance range
AUSTIN, Texas – November 8, 2022 – Iteris, Inc. (NASDAQ: ITI), the global leader in smart mobility infrastructure management, today reported financial results for its fiscal second quarter 2023 ended September 30, 2022.
Fiscal 2023 Second Quarter Financial Summary
•Total revenue increased 18% year over year to a record $39.3 million
◦Service revenue increased 19% year over year to $18.5 million with continued strong adoption of Iteris’ ClearMobility® Platform
◦Product revenue increased 17% year over year to $20.8 million despite $0.9 million in shipments slipping out of the quarter due to global supply chain constraints
•GAAP net loss from continuing operations was $7.4 million, or $(0.17) per share, largely due to the company working through the majority of unusually high-cost inventory items associated with recent global supply chain constraints, compared to net loss from continuing operations of $2.1 million, or $(0.05) per share, in the same quarter a year ago
•Adjusted EBITDA loss in the second quarter was approximately $5.2 million, or (13.1)% of total revenues, largely due to global supply chain constraints, compared to $2.3 million, or 6.9% of total revenues, in the same quarter a year ago
•Total net bookings increased 15% year over year to $42.2 million
•Total ending backlog increased 34% year over year to a record $111.8 million
Management Commentary:
“We are pleased fiscal 2023 second quarter revenue rose 18% year over year to a record total $39.3 million,” said Joe Bergera, president and CEO of Iteris. “To meet customer commitments, we shipped an historic number of Vantage sensors despite global supply chain constraints requiring the use of expensive secondary market components. While this drove extraordinary costs of goods sold for the quarter, we were able to bleed high-cost inventory items through our income statement and reoptimize our inventory for alternative circuit boards we are bringing online at normalized component costs. As a result, our second quarter actions positioned Iteris for a critical inflection point in the second half of fiscal 2023.
“Indeed, we anticipate sustained above market revenue growth through the second half of fiscal 2023, because the availability of our redesigned circuit boards will enable us to accelerate the conversion rate of our record total ending backlog. Likewise, we expect gross profit margins for our Vantage sensor products to improve progressively throughout the quarter, returning to normal rates by the fiscal year end, due to favorable costs of goods sold for these new circuit board designs. Based on these combined factors, we forecast year over year revenue growth of approximately 20% and sequential improvements in profitability through the second half, enabling us to exit the fiscal year at approximately 10% adjusted EBITDA margins.”
Fiscal 2023 Second Half and Full Year Outlook
•Second half revenue growth is expected to be approximately 20% year over year due to the benefits of Iteris’ supply chain mitigation program and high levels of demand for its products and services
•Second half adjusted EBITDA is expected to be in the range of $3.5 million to $4.0 million, or 4.5% to 5.0% of revenue, due to the compounding financial benefits of the global supply chain mitigation program, enabling the Company to exit the fiscal year at approximately 10% adjusted EBITDA margins
•Second half net cashflow is expected to be in the range of $4.0 million to $6.0 million
•Full year fiscal 2023 revenue is expected to be in the range of $150 million to $155 million, representing growth of 14% year over year at the mid-point of the guidance range
•Full year adjusted EBITDA is expected to be in the range of -1.0% to -3.0% of full year fiscal 2023 revenue, reflecting global supply chain constraints realized in the fiscal 2023 first half as mentioned above
Earnings Conference Call
Page 1 of 7
Iteris will conduct a conference call today to discuss its fiscal second quarter results.
Date: Tuesday, November 8, 2022
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Toll-free dial-in number: +1-888-506-0062
International dial-in number: +1 973-528-0011
Conference ID: 375118
If joining by phone, please call the conference telephone number 5-10 minutes prior to the start time and ask to join the Iteris earnings call. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MKR Investor Relations at 1-213-277-5550.
To listen to the live webcast or view the press release, please visit the investor relations section of the Iteris website at www.iteris.com.
A telephone replay of the conference call will be available approximately two hours following the end of the call and will remain available for one week. To access the replay dial +1-877-481-4010 (US and Canada Toll Free), +1 919-882-2331 (International) and enter replay passcode 46774.
About Iteris, Inc.
Iteris is the world’s trusted technology ecosystem for smart mobility infrastructure management. Delivered through Iteris’ ClearMobility Platform, our cloud-enabled end-to-end solutions monitor, visualize and optimize mobility infrastructure around the world, and help bridge legacy technology silos to unlock the future of transportation. That’s why more than 10,000 public agencies and private-sector enterprises focused on mobility rely on Iteris every day. Visit www.iteris.com for more information, and join the conversation on Twitter, LinkedIn and Facebook.
Non-GAAP Fiscal 2023 Second Quarter Financial Results
In addition to results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), the company has included the following non-GAAP financial measure: Adjusted income (loss) from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, restructuring charges, and project loss reserves (“Adjusted EBITDA”). A discussion of the company’s use of this non-GAAP financial measure is set forth below in the financial statements portion of this release under the heading “Non-GAAP Financial Measures and Reconciliation.”
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This release may contain forward-looking statements, which speak only as of the date hereof and are based upon our current expectations and the information available to us at this time. Words such as "believes," "anticipates," "expects," "intends," "plans," "feels", "seeks," "estimates," "may," "will," "can," and variations of these words or similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements about the Company’s anticipated demand and growth opportunities, conversion of bookings to revenue, the impact and success of new solution offerings, the Company’s acquisitions, our future performance, growth and profitability, operating results, and financial condition and prospects. Such statements are subject to certain risks, uncertainties, and assumptions that are difficult to predict and actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors.
Important factors that may cause such a difference include, but are not limited to, federal, state and local government budgetary issues, spending and scheduling changes, funding constraints and delays, including in light of the ongoing COVID-19 pandemic; our ability to source key raw materials in light of the current global supply chain situation; the timing and amount of government funds allocated to overall transportation infrastructure projects and the transportation industry; our ability to replace large contracts once they have been completed; the effectiveness of efficiency, cost, and expense reduction efforts; our ability to successfully complete and integrate acquired assets and companies; our ability to specify, develop, complete, introduce, market and gain broad acceptance of our new and existing product and service offerings; risks related to our ability to recruit and/or retain key talent; the potential unforeseen impact of product and service offerings from competitors, increased competition in certain market segments, and such competitors’ patent coverage and claims; any softness in the markets that we address; adverse effects of the COVID-19 pandemic on our vendors and our employees; and the impact of general economic and political conditions and specific conditions in the markets we address, and the possible disruption in government spending and commercial activities, such as the COVID-19 pandemic, import/export tariffs, terrorist activities or armed conflicts in the United States and internationally. Further information on Iteris, Inc., including additional risk factors that may affect our forward-looking statements, as contained in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, and our other SEC filings that are available through the SEC's website (www.sec.gov).
Iteris Contact
Douglas Groves
Senior Vice President and Chief Financial Officer
Tel: (949) 270-9643
Page 2 of 7
Email: dgroves@iteris.com
Investor Relations
MKR Investor Relations, Inc.
Todd Kehrli
Tel: (213) 277-5550
Email: iti@mkr-group.com
Page 3 of 7
ITERIS, INC.
UNAUDITED CONDENSED
BALANCE SHEETS
(in thousands)
| September 30, 2022 | March 31, 2022 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 7,991 | $ | 23,689 | |||||||
| Restricted cash | 141 | 120 | |||||||||
| Trade accounts receivable, net | 26,540 | 25,628 | |||||||||
| Unbilled accounts receivable | 11,139 | 10,870 | |||||||||
| Inventories | 12,874 | 7,980 | |||||||||
| Prepaid expenses and other current assets | 3,597 | 4,076 | |||||||||
| Total current assets | 62,282 | 72,363 | |||||||||
| Property and equipment, net | 1,462 | 1,392 | |||||||||
| Right-of-use assets | 9,415 | 11,382 | |||||||||
| Intangible assets, net | 10,824 | 11,780 | |||||||||
| Goodwill | 28,340 | 28,340 | |||||||||
| Other assets | 1,096 | 1,120 | |||||||||
| Noncurrent assets of discontinued operations | — | 6 | |||||||||
| Total assets | $ | 113,419 | $ | 126,383 | |||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Trade accounts payable | $ | 14,796 | $ | 11,926 | |||||||
| Accrued payroll and related expenses | 10,550 | 11,409 | |||||||||
| Accrued liabilities | 5,451 | 5,623 | |||||||||
| Deferred revenue | 5,381 | 6,566 | |||||||||
| Current liabilities of discontinued operations | — | 163 | |||||||||
| Total current liabilities | 36,178 | 35,687 | |||||||||
| Long-term liabilities | 11,762 | 13,661 | |||||||||
| Noncurrent liabilities of discontinued operations | — | 172 | |||||||||
| Total liabilities | 47,940 | 49,520 | |||||||||
| Stockholders’ equity | 65,479 | 76,863 | |||||||||
| Total liabilities and stockholders’ equity | $ | 113,419 | $ | 126,383 | |||||||
Page 4 of 7
ITERIS, INC.
UNAUDITED CONDENSED
STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Product revenues | $ | 20,788 | $ | 17,736 | $ | 37,169 | $ | 35,762 | |||||||||||||||
| Service revenues | 18,471 | 15,511 | 35,757 | 31,570 | |||||||||||||||||||
| Total revenues | 39,259 | 33,247 | 72,926 | 67,332 | |||||||||||||||||||
| Cost of product revenues | 20,026 | 8,983 | 31,683 | 18,540 | |||||||||||||||||||
| Cost of service revenues | 12,682 | 13,134 | 24,533 | 23,569 | |||||||||||||||||||
| Cost of revenues | 32,708 | 22,117 | 56,216 | 42,109 | |||||||||||||||||||
| Gross profit | 6,551 | 11,130 | 16,710 | 25,223 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| General and administrative | 4,978 | 6,107 | 11,405 | 12,497 | |||||||||||||||||||
| Sales and marketing | 5,674 | 4,895 | 10,872 | 9,482 | |||||||||||||||||||
| Research and development | 2,173 | 1,829 | 4,309 | 3,594 | |||||||||||||||||||
| Amortization of intangible assets | 651 | 668 | 1,319 | 1,336 | |||||||||||||||||||
| Restructuring charges | — | — | 707 | — | |||||||||||||||||||
| Total operating expenses | 13,476 | 13,499 | 28,612 | 26,909 | |||||||||||||||||||
| Operating loss | (6,925) | (2,369) | (11,902) | (1,686) | |||||||||||||||||||
| Non-operating income (expense): | |||||||||||||||||||||||
| Other income, net | 117 | 30 | 94 | 48 | |||||||||||||||||||
| Interest income (expense), net | (300) | 1 | (332) | 4 | |||||||||||||||||||
| Loss from continuing operations before income taxes | (7,108) | (2,338) | (12,140) | (1,634) | |||||||||||||||||||
| (Provision) benefit for income taxes | (289) | 249 | (122) | 174 | |||||||||||||||||||
| Net loss from continuing operations | (7,397) | (2,089) | (12,262) | (1,460) | |||||||||||||||||||
| Loss from discontinued operations before gain on sale, net of tax | — | (58) | — | (76) | |||||||||||||||||||
| Net loss from discontinued operations, net of tax | — | (58) | — | (76) | |||||||||||||||||||
| Net loss | $ | (7,397) | $ | (2,147) | $ | (12,262) | $ | (1,536) | |||||||||||||||
| Loss per share - basic and diluted: | |||||||||||||||||||||||
| Loss per share from continuing operations | $ | (0.17) | $ | (0.05) | $ | (0.29) | $ | (0.03) | |||||||||||||||
| Loss per share from discontinued operations | $ | — | $ | — | $ | — | $ | — | |||||||||||||||
| Net loss per share | $ | (0.17) | $ | (0.05) | $ | (0.29) | $ | (0.03) | |||||||||||||||
| Shares used in basic and diluted per share calculations | 42,288 | 42,282 | 42,334 | 42,079 | |||||||||||||||||||
Page 5 of 7
ITERIS, INC.
Non-GAAP Financial Measures and Reconciliation
In addition to results presented in accordance with GAAP, the company has included the following non-GAAP financial measure in this release: Adjusted income (loss) from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, restructuring charges, and project loss reserves (“Adjusted EBITDA”).
When viewed with our financial results prepared in accordance with GAAP and accompanying reconciliations, we believe Adjusted EBITDA provides additional useful information to clarify and enhance the understanding of the factors and trends affecting our past performance and future prospects. We define this measure, explain how it is calculated and provide reconciliations of this measure to the most comparable GAAP measure in the table below. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. This is not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by operating activities as measures of our liquidity. The presentation of this measure should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.
We use the Adjusted EBITDA non-GAAP operating performance measure internally as a complementary financial measure to evaluate the performance and trends of our businesses. We present Adjusted EBITDA and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our operating commitments.
Adjusted EBITDA and the related financial ratios have limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations include:
•They do not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
•They do not reflect changes in, or cash requirements for, our working capital needs;
•Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;
•They are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
•They do not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and
•Other companies in our industry may calculate Adjusted EBITDA differently from us, limiting their usefulness as comparative measures.
Because of these limitations, Adjusted EBITDA and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as supplemental information. See our Unaudited Condensed Financial Statements contained in this Press Release. However, in spite of the above limitations, we believe that Adjusted EBITDA and the related financial ratios are useful to an investor in evaluating our results of operations because these measures:
•Are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
•Help investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and
•Are used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.
The following financial items have been added back to or subtracted from our net income when calculating Adjusted EBITDA:
•Interest expense. Iteris excludes interest expense because it does not believe this item is reflective of ongoing business and operating results. This amount may be useful to investors for determining current cash flow. This amount may be useful to investors for determining current cash flow. For the three and six months ended September 30, 2022, interest expense includes amortization of the remaining capitalized deferred financing costs due to the termination of the Credit Agreement
Page 6 of 7
•Income tax. This amount may be useful to investors because it represents the taxes that might be payable for the period and the change in deferred taxes during the period, and therefore could reduce cash flow available for use in our business.
•Depreciation. Iteris excludes depreciation expense primarily because it is a non-cash expense. These amounts may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations.
•Amortization. Iteris incurs amortization of intangible assets in connection with acquisitions. Iteris also incurs amortization related to capitalized software development costs. Iteris excludes these items because it does not believe that these expenses are reflective of ongoing operating results in the period incurred. These amounts may be useful to investors because it represents the estimated attrition of our acquired customer base and the diminishing value of product rights.
•Stock-based compensation. These expenses consist primarily of expenses from employee and director equity based compensation plans. Iteris excludes stock-based compensation primarily because they are non-cash expenses and Iteris believes that it is useful to investors to understand the impact of stock-based compensation to its results of operations and current cash flow.
•Restructuring charges. These expenses consist primarily of employee separation expenses, facility termination costs, and other expenses associated with Company restructuring activities. Iteris excludes these expenses as it does not believe that these expenses are reflective of ongoing operating results in the period incurred. These amounts may be useful to our investors in evaluating our core operating performance.
•Project loss reserves. These expenses consist primarily of expenses incurred to complete a software development contract that will not be recoverable and largely related to previously incurred and capitalized costs for non-recurring engineering activity. Iteris excludes these expenses as it does not believe that these expenses are reflective of ongoing operating results in the period incurred. These amounts may be useful to our investors in evaluating our core operating performance.
Reconciliations of net loss from continuing operations to Adjusted EBITDA and the presentation of Adjusted EBITDA as a percentage of net revenues were as follows:
| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| (In Thousands) | (In Thousands) | ||||||||||||||||||||||
| Net loss from continuing operations | $ | (7,397) | $ | (2,089) | $ | (12,262) | $ | (1,460) | |||||||||||||||
| Income tax expense (benefit) | 289 | (249) | 122 | (174) | |||||||||||||||||||
| Depreciation expense | 149 | 194 | 308 | 426 | |||||||||||||||||||
| Amortization expense | 804 | 815 | 1,626 | 1,618 | |||||||||||||||||||
| Interest expense | 300 | — | 332 | — | |||||||||||||||||||
| Stock-based compensation | 696 | 834 | 1,544 | 1,628 | |||||||||||||||||||
| Other adjustments: | |||||||||||||||||||||||
| Restructuring charges | — | — | 707 | — | |||||||||||||||||||
| Project loss | $ | 2,805 | $ | — | $ | 3,394 | |||||||||||||||||
| Total adjustments | $ | 2,238 | $ | 4,399 | $ | 4,639 | $ | 6,892 | |||||||||||||||
| Adjusted EBITDA | $ | (5,159) | $ | 2,310 | $ | (7,623) | $ | 5,432 | |||||||||||||||
| Percentage of total revenues | (13.1) | % | 6.9 | % | (10.5) | % | 8.1 | % | |||||||||||||||
Page 7 of 7